Total submissions: 8
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000958815 | SCV001105692 | benign | not provided | 2018-05-24 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV001012494 | SCV001172952 | benign | Hereditary cancer-predisposing syndrome | 2018-09-19 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Gene |
RCV000958815 | SCV002006319 | likely benign | not provided | 2021-02-23 | criteria provided, single submitter | clinical testing | |
ARUP Laboratories, |
RCV000958815 | SCV002050099 | benign | not provided | 2024-09-13 | criteria provided, single submitter | clinical testing | |
Sema4, |
RCV001012494 | SCV002535972 | benign | Hereditary cancer-predisposing syndrome | 2021-03-03 | criteria provided, single submitter | curation | |
Center for Genomic Medicine, |
RCV002282412 | SCV002570189 | likely benign | not specified | 2025-03-04 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV000958815 | SCV005225240 | likely benign | not provided | criteria provided, single submitter | not provided | ||
Department of Pathology and Laboratory Medicine, |
RCV005392586 | SCV006057932 | benign | Endometrial carcinoma; Familial adenomatous polyposis 4 | 2021-07-06 | criteria provided, single submitter | clinical testing |